Israel Englander Bausch Health Companies Inc. Transaction History

Millennium Management LLC

$213 Billion
Q3 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Millennium Management LLC holds 469,869 shares of BHC stock, worth $2.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

469,869

Previous 556,189 15.52%

Holding current value

$2.95 Million

Previous $3.7 Million 18.2%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$5.71 - $8.34 $492,887 - $719,908	-86,320 Reduced 15.52%	469,869 $3.03 Million
Q2 2025 Aug 14, 2025	BUY	$4.32 - $6.66 $563,016 - $867,984	130,328 Added 30.6%	556,189 $3.7 Million
Q1 2025 May 15, 2025	SELL	$6.16 - $7.94 $107,775 - $138,918	-17,496 Reduced 3.95%	425,861 $2.76 Million
Q4 2024 Feb 14, 2025	BUY	$7.34 - $9.78 $304,925 - $406,290	41,543 Added 10.34%	443,357 $3.57 Million
Q3 2024 Nov 14, 2024	SELL	$5.22 - $8.26 $2.59 Million - $4.1 Million	-496,876 Reduced 55.29%	401,814 $3.27 Million

Q2 2024 Aug 14, 2024	SELL	$6.1 - $10.41 $1.54 Million - $2.62 Million	-252,048 Reduced 21.9%	898,690 $6.26 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $3.76 Million - $5.13 Million	483,918 Added 72.57%	1,150,738 $12.2 Million
Q4 2023 Feb 14, 2024	SELL	$6.53 - $8.23 $4.13 Million - $5.2 Million	-631,755 Reduced 48.65%	666,820 $5.35 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $208,619 - $320,953	36,472 Added 2.89%	1,298,575 $10.4 Million
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $1.37 Million - $2.15 Million	-217,925 Reduced 14.72%	1,262,103 $10.2 Million
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $9.01 Million - $11.7 Million	1,480,028 New	1,480,028 $9.3 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $377,349 - $1.26 Million	-53,449 Reduced 2.8%	1,858,196 $15.5 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $9.79 Million - $12.6 Million	-453,072 Reduced 19.16%	1,911,645 $43.7 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $29.1 Million - $36.7 Million	1,266,772 Added 115.38%	2,364,717 $65.3 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $24.5 Million - $29.4 Million	-978,391 Reduced 47.12%	1,097,945 $30.6 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $23.1 Million - $27.5 Million	841,296 Added 68.12%	2,076,336 $60.9 Million
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $5.96 Million - $9.59 Million	279,051 Added 29.19%	1,235,040 $39.2 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $6.51 Million - $8.98 Million	425,057 Added 80.06%	955,989 $19.9 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $6.28 Million - $8.5 Million	422,318 Added 388.82%	530,932 $8.25 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $13 Million - $20 Million	-975,591 Reduced 89.98%	108,614 $1.99 Million
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $14.1 Million - $32.8 Million	1,084,205 New	1,084,205 $16.8 Million
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $10.4 Million - $17.6 Million	-550,673 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $3.51 Million - $4.31 Million	168,125 Added 43.95%	550,673 $12 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $14.6 Million - $18.8 Million	-711,479 Reduced 65.03%	382,548 $9.65 Million
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $3.55 Million - $4.61 Million	-175,322 Reduced 13.81%	1,094,027 $27 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $13.2 Million - $21.3 Million	750,415 Added 144.61%	1,269,349 $23.4 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $10.7 Million - $13.3 Million	518,934 New	518,934 $13.3 Million

Others Institutions Holding BHC

# of Institutions

262

Shares Held

207M

Call Options Held

2.54M

Put Options Held

6.46M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.27B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account